CARE-MH
Recruiting
Official title: CARE-MH: Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington’s Disease Patients
The goal of this trial is to see whether a program that combines physical exercise and brain activities at the same time helps people more than a program where these activities are done one after the other.
Right now, there is no cure for Huntington’s disease (HD), and medications don’t do much to improve symptoms—especially movement problems.
However, things like physical exercise and activities that challenge the brain seem promising for slowing down how symptoms get worse in conditions like HD. Using “exergames” (video games that involve physical movement) is becoming more common. These tools combine exercise and mental stimulation in a fun and engaging way, and they show encouraging potential for helping people manage symptoms of neurodegenerative diseases.
This an open label.
Phase: not applicable
Subtype: Interventional Therapeutic
Primary Purpose: Supportive Care
Intervention Type: behavourial
Primary Intervention: physical activity and cognitive stimulation
Duration: 12 weeks/180 days
Ages Eligible
for Study:
18 Years and older
Sexes Eligible
for Study:
All
Accepts Healthy Volunteers:
No
- Adults at inclusion
- Huntington’s disease diagnosed and confirmed by genetic analysis
- Patient with stage 1-2 HD with a motor UHDRS score ≥ 5 and a CFT between 6 < CFT ≤ 13
- Patient with written informed consent or third-party consent
- Affiliated or beneficiary of a social security scheme
- Poor understanding of the French language
- Participation in interventional research modifying management
- History likely to interfere with cognition (established stroke, sequelae of traumatic brain injury, active epilepsy, learning disorders, alcohol dependence syndrome, drug use, psychiatric disorders), severe cognitive deficit (MMSE <16), clinically significant pathological condition which, in the investigator’s opinion, could interfere with the subject’s safety or the evaluation of study results
- Pregnant or breast-feeding women
- Persons deprived of their liberty by administrative or judicial decision
- Persons under compulsory psychiatric care
LOCATIONS
COUNTRIES
France
TRIAL SITE: Angers University hospital
Name: Clarisse SCHERER GAGOU, MD
Tel: +33 2 41 35 55 46 ext +33
Email: ClScherer@chu-angers.fr
